Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia

por Oram, S H, Thoms, J, Sive, J I, Calero-Nieto, F J, Kinston, S J, Schütte, J, Knezevic, K, Lock, R B, Pimanda, J E, Göttgens, B
Publicado 2013

A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia

por Samuels, A L, Beesley, A H, Yadav, B D, Papa, R A, Sutton, R, Anderson, D, Marshall, G M, Cole, C H, Kees, U R, Lock, R B
Publicado 2014

MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells

por Peaston, A E, Gardaneh, M, Franco, A V, Hocker, J E, Murphy, K M, Farnsworth, M L, Catchpoole, D R, Haber, M, Norris, M D, Lock, R B, Marshall, G M
Publicado 2001

The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer Care

por Wakefield, C.E., Doolan, E.L., Fardell, J.E., Signorelli, C., Quinn, V.F., Tucker, K.M., Patenaude, A.F., Marshall, G.M., Lock, R.B., Georgiou, G., Cohn, R.J.
Publicado 2018